Stockholm - Delayed Quote SEK

Xbrane Biopharma AB (publ) (XBRANE.ST)

Compare
0.2150 +0.0350 (+19.44%)
At close: 5:29 PM GMT+2
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
653,508.0000
690,515.0000
688,427.0000
463,763.0000
--
Total Liabilities Net Minority Interest
482,173.0000
265,627.0000
256,686.0000
206,055.0000
--
Total Equity Gross Minority Interest
171,335.0000
424,888.0000
431,741.0000
257,708.0000
--
Total Capitalization
284,232.0000
424,888.0000
431,741.0000
257,708.0000
--
Common Stock Equity
171,335.0000
424,888.0000
431,741.0000
257,708.0000
--
Capital Lease Obligations
56,082.0000
38,220.0000
44,381.0000
6,260.0000
--
Net Tangible Assets
71,665.0000
322,893.0000
382,069.0000
195,172.0000
--
Working Capital
135,136.0000
276,955.0000
341,341.0000
185,489.0000
--
Invested Capital
346,732.0000
424,888.0000
431,741.0000
257,708.0000
--
Tangible Book Value
71,665.0000
322,893.0000
382,069.0000
195,172.0000
--
Total Debt
231,479.0000
38,220.0000
44,381.0000
6,260.0000
--
Net Debt
109,995.0000
--
--
--
--
Share Issued
262,955.0660
242,628.5960
220,875.2010
195,828.2560
--
Ordinary Shares Number
262,955.0660
242,628.5960
220,875.2010
195,828.2560
--
12/31/2019 - 2/3/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers